Ligand Pharmaceuticals (LGNYZ) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Ligand Pharmaceuticals (LGNYZ) over the last 13 years, with Q4 2022 value amounting to $17.0 million.
- Ligand Pharmaceuticals' Shares Outstanding rose 109.74% to $17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $17.0 million, marking a year-over-year increase of 109.74%. This contributed to the annual value of $17.0 million for FY2022, which is 109.74% up from last year.
- According to the latest figures from Q4 2022, Ligand Pharmaceuticals' Shares Outstanding is $17.0 million, which was up 109.74% from $16.9 million recorded in Q1 2022.
- Over the past 5 years, Ligand Pharmaceuticals' Shares Outstanding peaked at $21.3 million during Q1 2018, and registered a low of $16.0 million during Q1 2020.
- For the 5-year period, Ligand Pharmaceuticals' Shares Outstanding averaged around $17.9 million, with its median value being $16.8 million (2019).
- Its Shares Outstanding has fluctuated over the past 5 years, first plummeted by 1898.3% in 2019, then soared by 427.24% in 2021.
- Over the past 5 years, Ligand Pharmaceuticals' Shares Outstanding (Quarter) stood at $20.8 million in 2018, then dropped by 18.98% to $16.8 million in 2019, then decreased by 4.42% to $16.1 million in 2020, then increased by 4.27% to $16.8 million in 2021, then rose by 1.1% to $17.0 million in 2022.
- Its last three reported values are $17.0 million in Q4 2022, $16.9 million for Q1 2022, and $16.8 million during Q4 2021.